Australia’s National Health and Medical Research Council (NHMRC) releases draft interim advice saying puberty blockers should remain available for some trans and gender-diverse children under 18 with gender incongruence. Multiple outlets describe the guidance as the product of a review of international evidence and as intended to respond to existing restrictions.

Several articles note that the advice is conditional and framed around clinical circumstances, consultation, and the need for further detail. They also say Queensland and the Northern Territory have not lifted their public-hospital bans, leaving the national guidance at odds with local rules.

Outlets differ in emphasis: some foreground parental appeals to Queensland, others focus on what the NHMRC draft recommendation contains, including timing for fuller guidelines, or highlight the policy conflict between federal medical advice and state-level restrictions. Coverage generally agrees that this is draft or interim national guidance and that it does not immediately change restrictions in Queensland and the NT.